Z

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357

Watchlist Manager
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357
Watchlist
Price: 22.18 CNY -4.81% Market Closed
Market Cap: 11.6B CNY
Have any thoughts about
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd?
Write Note

Gross Margin
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

94.4%
Current
95%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
94.4%
=
Gross Profit
853.6m
/
Revenue
904.6m

Gross Margin Across Competitors

Country CN
Market Cap 11.6B CNY
Gross Margin
94%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 710.5B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 373.5B USD
Gross Margin
69%
Country US
Market Cap 251.1B USD
Gross Margin
77%
Country CH
Market Cap 202.7B CHF
Gross Margin
73%
Country CH
Market Cap 183.3B CHF
Gross Margin
75%
Country UK
Market Cap 162.4B GBP
Gross Margin
82%
Country IE
Market Cap 146B USD
Gross Margin
68%
No Stocks Found

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
Glance View

Market Cap
11.6B CNY
Industry
Pharmaceuticals

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of biopharmaceutical products. The company is headquartered in Huzhou, Zhejiang and currently employs 1,488 full-time employees. The company went IPO on 2014-01-21. The firm's main products include Dermatophagoides Farinae Drops and Dermatophagoides Farinae Skin Prick Diagnostic Kits. The firm's products are primarily used for the treatment of allergic rhinitis caused by dust mite allergy, the desensitization of allergic asthma and the in-vivo diagnosis of dust mite drops. The firm distributes its products in domestic market.

Intrinsic Value
22.51 CNY
Undervaluation 1%
Intrinsic Value
Price
Z

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
94.4%
=
Gross Profit
853.6m
/
Revenue
904.6m
What is the Gross Margin of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd?

Based on Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 94.4%.